You are here

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis

Authors

  • Richard M Yeker Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Iago Pinal-Fernandez Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, Maryland, USA Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Takayuki Kishi Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Katherine Pak Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Ira N Targoff US Department of Veterans Affairs Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Frederick W Miller Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Lisa G Rider Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Andrew L Mammen Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, Maryland, USA Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • for the Childhood Myositis Heterogeneity Collaborative Study Group
    Google scholar articles
  1. Correspondence to Dr Andrew L Mammen, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD 20892, USA; andrew.mammen{at}nih.gov
View Full Text

Citation

Yeker RM, Pinal-Fernandez I, Kishi T for the Childhood Myositis Heterogeneity Collaborative Study Group, et al
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis
Annals of the Rheumatic Diseases 2018;77:714-719.

Publication history

  • Received September 25, 2017
  • Revised December 5, 2017
  • Accepted January 3, 2018
  • First published January 23, 2018.
Online issue publication 
April 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.